`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`————————————————
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`————————————————
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`v.
`
`GENENTECH, INC.,
`Patent Owner
`
`————————————————
`
`Case IPR2016-01694
`Patent 6,407,213
`————————————————
`
`JOINT MOTION TO TERMINATE PROCEEDING
` PURSUANT TO 35 U.S.C. § 317(a)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 35 U.S.C. § 317(a), Petitioner Mylan Pharmaceuticals Inc.
`
`(“Mylan” or “Petitioner”) and Patent Owner Genentech, Inc. (“Genentech” or
`
`“Patent Owner”) jointly request termination of IPR2016-01694, which is directed
`
`to U.S. Patent No 6,407,213 (the “’213 Patent”).
`
`I.
`
`STATEMENT OF PRECISE RELIEF REQUESTED
`
`Pursuant to 35 U.S.C. § 317(a), Petitioner and Patent Owner jointly request
`
`termination of this inter partes review pursuant to a settlement.
`
`II.
`
`STATEMENT OF FACTS
`
`No decision on institution has been issued yet in this case. Further,
`
`Petitioner and Patent Owner have reached an agreement to settle this inter partes
`
`review proceeding. A “Joint Request That Settlement Agreement Be Treated as
`
`Business Confidential Information and Kept Separate Pursuant to 35 U.S.C.
`
`§ 317(b) and 37 C.F.R. § 42.74” is being filed concurrently with this Joint Motion
`
`to Terminate in reference to sealing of the settlement agreement. See 35 U.S.C.
`
`§ 317(b) (requiring parties to file agreements in writing with the Office). The
`
`Board previously provided authorization to file this motion on February 28, 2017.
`
`(Paper 19.)
`
`A joint motion to terminate generally must “(1) include a brief explanation
`
`as to why termination is appropriate; (2) identify all parties in any related litigation
`
`involving the patents at issue; (3) identify any related proceedings currently before
`
`1
`
`
`
`
`
`
`
`
`
`
`
`the Office, and (4) discuss specifically the current status of each such related
`
`litigation or proceeding with respect to each party to the litigation or proceeding.”
`
`Heartland Tanning, Inc. v. Sunless, Inc., IPR2014-00018, Paper 26 at 2 (PTAB
`
`Jul. 28, 2014).
`
`(1) Brief Explanation. Termination is appropriate in this case because the
`
`parties have settled their dispute. A “Joint Request That Settlement Agreement Be
`
`Treated as Business Confidential Information and Kept Separate Pursuant to 35
`
`U.S.C. § 317(b) and 37 C.F.R. § 42.74” is being filed concurrently with this Joint
`
`Motion to Terminate in reference to sealing of the settlement agreement.
`
`(2) Related Litigation. There is currently no litigation involving the
`
`challenged patent.
`
`(3)(4) Related Proceeding before the Patent Office and Its Status. Petitioner
`
`filed a separate petition challenging certain claims of the ’213 Patent in IPR2016-
`
`01693. Petitioner and Patent Owner are concurrently filing a Joint Motion to
`
`Terminate Proceeding Pursuant to 35 U.S.C. § 317(a) in IPR2016-01693.
`
`Petitioner and Patent Owner are unaware of any pending judicial or administrative
`
`matter that would affect, or be affected by, a decision in this inter partes review.
`
`III. ARGUMENT
`
`The Board should terminate this case as the parties jointly request, for the
`
`2
`
`following reasons.
`
`
`
`
`
`
`
`
`
`
`First, Petitioner and Patent Owner have met the statutory requirement that
`
`they file a “joint request” to terminate before the Office “has decided the merits of
`
`the proceeding.” 35 U.S.C. § 317(a). Under section 317(a), an inter partes review
`
`shall be terminated upon such joint request “unless the Office has decided the
`
`merits of the proceeding before the request for termination is filed.” There are no
`
`other preconditions of 35 U.S.C. § 317(a).
`
`Second, the parties have reached a settlement as to all the disputes in this
`
`proceeding and as to the ’213 Patent. A true copy of the settlement agreement is
`
`filed concurrently herewith. See Ex. 1132. The parties request that the settlement
`
`agreement be treated as business confidential information, and be kept separate
`
`from the files of this proceeding in accordance with 37 C.F.R. § 42.74(c). No
`
`other such agreements, written or oral, exist between or among the parties.
`
`Accordingly, the parties in the present proceeding jointly certify that there
`
`are no other written or oral agreements or understandings, including any collateral
`
`agreements, between them, including but not limited to licenses, covenants not to
`
`sue, confidentiality agreements, payment agreements, or other agreements of any
`
`kind, that are made in connection with or in contemplation of, the termination of
`
`the instant proceeding.
`
`Third, a termination of this proceeding will conserve the Board’s resources
`
`and obviate the need for any more Board involvement in this matter.
`
`3
`
`
`
`
`
`
`
`
`
`
`
` IV. CONCLUSION
`
`For the foregoing reasons, Petitioner and Patent Owner respectfully request
`
`termination of this inter partes review of the ’213 Patent.
`
`Respectfully submitted,
`
`/Deanne M. Mazzochi/
`Deanne M. Mazzochi
`Reg. No. 50,158
`
`RAKOCZY MOLINO MAZZOCHI
`SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: (312) 222-6305
`Fax: (312) 222-6325
`dmazzochi@rmmslegal.com
`
`Counsel for Petitioner Mylan
`Pharmaceuticals Inc.
`
`
`
`Dated: March 7, 2017
`
`
`
`4
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/David L. Cavanaugh /
`David L. Cavanaugh
`Reg. No. 36,476
`
`David L. Cavanaugh
`WILMER CUTLER PICKERING HALE
` AND DORR LLP
`1875 Pennsylvania Avenue NW
`Washington, DC 20006
`David.Cavanaugh@wilmerhale.com
`Telephone: 202-663-6025
`Facsimile: 202-663-6363
`
`Attorney for Genentech, Inc.
`
`
`
`Dated: March 7, 2017
`
`
`
`
`5
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on March 7, 2017, the
`
`
`
`
`
`foregoing document is being served by E-mail by agreement of the parties to the
`
`following counsel of record for the Patent Owner:
`
`Robert J. Gunther, Jr.
`Pro hac vice
`robert.gunther@wilmerhale.com
`Adam R. Brausa
`Reg. No. 60,287
`abrausa@durietangri.com
`Owen K. Allen
`Reg. No. 71,118
`owen.allen@wilmerhale.com
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
` /Deanne M. Mazzochi/
`Deanne M. Mazzochi (Reg. No. 50,158)
`dmazzochi@rmmslegal.com
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Telephone: (312) 222-6305
`Facsimile: (312) 222-6325
`
`
`
`6
`
`David L. Cavanaugh
`Reg. No. 36,476
`WILMER CUTLER PICKERING HALE
` AND DORR LLP
`1875 Pennsylvania Avenue NW
`Washington, DC 20006
`David.Cavanaugh@wilmerhale.com
`Telephone: 202-663-6025
`Facsimile: 202-663-6363
`
`
`
`
`Dated: March 7, 2017
`
`
`
`
`
`
`
`
`
`
`
`